SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001354488-15-004747
Filing Date
2015-10-29
Accepted
2015-10-29 12:37:49
Documents
5
Period of Report
2015-10-02
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT AMENDMENT 2 tbuff_8ka.htm 8-K/A 37047
2 CONSENT OF PWC tbuff_ex231.htm EX-23.1 7149
3 AUDITED STATEMENTS OF REVENUE AND RELATED EXPENSES tbuff_ex992.htm EX-99.2 51688
4 PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS tbuff_ex993.htm EX-99.3 477137
5 logo.jpg GRAPHIC 2808
  Complete submission text file 0001354488-15-004747.txt   578231
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-31198 | Film No.: 151182865
SIC: 2834 Pharmaceutical Preparations